Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?

被引:16
|
作者
Alizadeh, Zeinab [1 ]
Baradaran, Hamid Reza [1 ,2 ,3 ]
Kohansal, Karim [4 ]
Hadaegh, Farzad [4 ]
Azizi, Fereidoun [5 ]
Khalili, Davood [4 ,6 ]
机构
[1] Iran Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran
[2] Univ Aberdeen, Inst Appl Hlth Sci, Sch Med Med Sci & Nutr, Ageing Clin & Expt Res Team, Aberdeen, Scotland
[3] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran
[5] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran
[6] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Dept Biostat & Epidemiol, Tehran, Iran
来源
关键词
normoglycemia; pre-diabetes; type; 2; diabetes; Cardiometabolic disorders; progression; regression; NORMAL GLUCOSE REGULATION; FAMILY-HISTORY; RISK; NORMALIZATION; TOLERANCE; HEALTH; IMPACT;
D O I
10.3389/fendo.2022.1041808
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundWe aimed to determine the predictors of regression to normoglycemia and progression to diabetes among subjects with pre-diabetes in a single model concurrently. MethodsThe present study included 1329 participants aged 20 to 70 years with prediabetes from the population-based cohort of the Tehran Lipid and Glucose Study, with a 10-year follow-up. Glycemic status at follow-up was categorized as regression to normoglycemia: fasting plasma glucose [FPG] of <5.55 and 2h-plasma glucose [PG] of <7.77 mmol/L, and not taking antidiabetic medications. Glycemic status at follow-up was categorized as progression to diabetes: FPG >= 7 or 2h-PG of >= 11.1 mmol/L, or taking antidiabetic medications. Glycemic status determined whether the patients remained in prediabetes category (isolated impaired fasting glycaemia [iIFG] [(5.55 <= FPG<7 and 2h-PG<7.77 mmol/L); isolated impared glucose tolarence [iIGT] (7.77 <= 2h-PG<11.1 and FGP<5.55 mmol/L)]. With prediabetes as a reference, multinomial logistic regression was utilized to identify the determinants of glycemic changes. ResultsApproximately 40% of participants returned to normoglycemia (n = 578), and similar percentage of participants progressed to diabetes (n = 518). Based on the multivariable multinomial model, regression to normoglycemia was associated with age (relative risk ratio [RRR] = 0.97; 95% CI, 0.95-0.99), female sex (RRR = 1.72; 95% CI, 1.18-2.50), high education level of >= 12 years (RRR = 2.10; 95% CI, 1.19-3.70), and combined IFG/impaired glucose tolerance (IGT) versus IFG (RRR = 0.45; 95% CI, 0.29-0.70). The risk of progression to diabetes increased with body mass index (RRR = 1.10; 95% CI, 1.05-1.15), waist circumference (RRR = 0.97; 95% CI, 0.96-0.99), positive familial history of diabetes (RRR = 1.62; 95% CI, 1.07-2.45), and combined IFG/IGT versus IFG (RRR = 2.54; 95% CI, 1.71-3.77). ConclusionA small percentage of patients with prediabetes remain in this condition, but the majority go on to develop diabetes or regress to normoglycemia. Both directions had distinct predictors.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Determinants of the progression to type 2 diabetes and regression to normoglycemia in people with pre-diabetes: A population-based cohort study over ten years
    Kohansal, Karim
    Ahmadi, Nooshin
    Hadaegh, Farzad
    Alizadeh, Zeinab
    Azizi, Fereidoun
    Habibi-Moeini, Ali Siamak
    Khalili, Davood
    PRIMARY CARE DIABETES, 2022, 16 (06) : 797 - 803
  • [2] White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia
    Grosu, Sergio
    Lorbeer, Roberto
    Hartmann, Felix
    Rospleszcz, Susanne
    Bamberg, Fabian
    Schlett, Christopher L.
    Galie, Franziska
    Selder, Sonja
    Auweter, Sigrid
    Heier, Margit
    Rathmann, Wolfgang
    Mueller-Peltzer, Katharina
    Ladwig, Karl-Heinz
    Peters, Annette
    Ertl-Wagner, Birgit B.
    Stoecklein, Sophia
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [3] Invitation to do remission of pre-diabetes to normoglycemia
    Jensen, Olaf Chresten
    INTERNATIONAL MARITIME HEALTH, 2024, 75 (02) : 135 - 136
  • [4] Prevalence of Pre-Diabetes and Characteristics of Patients at High Risk for Progression to Type 2 Diabetes
    Mehra, Maneesha
    Dibello, Julia
    Levy, Brian L.
    DIABETES, 2009, 58 : A582 - A582
  • [5] Risk of progression from pre-diabetes to type 2 diabetes in a large UK adult cohort
    Gardner, Michael P.
    Wang, Jingya
    Hazlehurst, Jonathan M.
    Sainsbury, Chris
    Blissett, Jacqueline
    Nirantharakumar, Krishnarajah
    Thomas, Neil
    Bellary, Srikanth
    DIABETIC MEDICINE, 2023, 40 (03)
  • [6] Diagnosis of Type 2 Diabetes and Pre-diabetes Using Machine Learning
    Severeyn, Erika
    Wong, Sara
    Velasquez, Jesus
    Perpinan, Gilberto
    Herrera, Hector
    Altuve, Miguel
    Diaz, Jose
    VIII LATIN AMERICAN CONFERENCE ON BIOMEDICAL ENGINEERING AND XLII NATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING, 2020, 75 : 792 - 802
  • [7] OUTCOMES OF CONTINUOUS REMOTE CARE IN PRE-DIABETES AND TYPE 2 DIABETES
    Ratner, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A21 - A21
  • [8] Epigenetic profiles of pre-diabetes transitioning to type 2 diabetes and nephropathy
    VanderJagt, Thomas A.
    Neugebauer, Monica H.
    Morgan, Marilee
    Bowden, Donald W.
    Shah, Vallabh O.
    WORLD JOURNAL OF DIABETES, 2015, 6 (09) : 1113 - 1121
  • [9] Dietary pattern scores in relation to pre-diabetes regression to normal glycemia or progression to type 2 diabetes: a 9-year follow-up
    Parvin Mirmiran
    Shabnam Hosseini
    Zahra Bahadoran
    Fereidoun Azizi
    BMC Endocrine Disorders, 23
  • [10] Dietary pattern scores in relation to pre-diabetes regression to normal glycemia or progression to type 2 diabetes: a 9-year follow-up
    Mirmiran, Parvin
    Hosseini, Shabnam
    Bahadoran, Zahra
    Azizi, Fereidoun
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)